A cohort study of mortality predictors in patients with acute exacerbation of chronic fibrosing interstitial pneumonia

BMJ Open

Volumn 3, Issue 7, 2013, Pages

  Usui, Yutaka ^a   Kaga, Akiko ^a   Sakai, Fumikazu ^a   Shiono, Ayako ^a   Komiyama, Ken Ichiro ^a   Hagiwara, Koichi ^a   Kanazawa, Minoru ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYCLOSPORIN; D DIMER; METHYLPREDNISOLONE; PROCALCITONIN; SURFACTANT PROTEIN D;

AGED; ARTICLE; CHRONIC FIBROSING INTERSTITIAL PNEUMONIA; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE EXACERBATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERSTITIAL PNEUMONIA; JAPAN; LEUKOCYTE COUNT; LUNG EMPHYSEMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PREVALENCE; RETROSPECTIVE STUDY; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNIVERSITY HOSPITAL;

EID: 84883335084     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002971     Document Type: Article

References (34)

1. Kondoh Y, Taniguchi H, Kawabata Y., et al. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 1993; 103: 1808-12.
2. Park IN, Kim DS, Shim T.S., et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007; 132: 214-20. (Pubitemid 47068224)
3. Silva CI, Müller NL, Fujimoto K., et al. Acute exacerbation of chroni interstitial pneumonia: high-resolution computed tomography and pathologic findings. J Thorac Imaging 2007; 22: 221-9. (Pubitemid 47329825)
4. Olson AL, Huie TJ, Groshong S.D., et al. Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series. Chest 2008; 134: 844-50.
5. Richard L, Kradin RL, Subba R, et al Case records of the Massachusetts General Hospital. Case 12-2010: an 89-year-old man with progressive dyspnoea. N Engl J Med 2010; 362: 1522-31.
6. Ley B, Collard HR, King TE Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Me 2011; 183: 431-40.
7. Kondoh Y, Taniguchi H, Katsuta T., et al. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27: 103e10.
8. Song JW, Hong SB, Lim C.M., et al. Acute exacerbation of idiopathi pulmonary fibrosis: incidence, risk factors and outcome. Eur Respi 2011; 37: 356-63.
9. Akira M, Kozuka T, Yamamoto S., et al. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am Respir Crit Care Med 2008; 178: 372-8.
10. Fujimoto K, Taniguchi H, Johkoh T., et al. Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality. Eur Radiol 2012; 22: 83-92.
11. Abe S, Azuma A, Mukae H., et al. Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acut exacerbation: a multicenter retrospective analysis. Intern Med 2012; 51: 1487-91.
12. Collard HR, Moore BB, Flaherty K.R., et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007; 176: 636-43. (Pubitemid 47503070)
13. Cottin V, Nunes H, Brillet P.Y., et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26: 586-93. (Pubitemid 41448654)
14. Raghu G, Collard HR, Egan J.J., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
15. Ichikado K, Suga M, Müller NL, et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med 2002; 165: 1551-6. (Pubitemid 34606673)
16. Akira M, Hamada H, Sakatani M., et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 1997; 168: 79-83. (Pubitemid 27014751)
17. Akira M, Inoue Y, Kitaichi M., et al. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings. Radiology 2009; 251: 271-9.
18. Bone RC, Balk RA, Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-55.
19. Kanda Y. Investigation of the freely-available easy-to-use software "EZR," (Easy R) for medical statistics. Bone Marrow Transplant 2013; 48: 452-8.
20. American Thoracic Society/European Respiratory Society International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
21. Alberti C, Brun-Buisson C, Goodman S.V., et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003; 168: 77-84. (Pubitemid 37046636)
22. Collard HR, Calfee CS, Wolters P.J., et al. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2010; 299:L3-7.
23. McClintock D, Zhuo H, Wickersham N., et al. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care 2008; 12:R41.
24. Assicot M, Gendrel D, Carsin H., et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-18. (Pubitemid 23066085)
25. Gilbert DN. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 2011; 52:S346-50.
26. Hensel M, Volk T, Döcke WD, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1998; 89: 93-104. (Pubitemid 28319572)
27. Nylen ES, Jeng J, Jordan M.H., et al. Pneumonitis-associated hyperprocalcitonemia. Am J Med Sci 1996; 312: 12-18.
28. Berg P, Lindhardt BØ. The role of procalcitonin in adult patients with community-acquired pneumonia - a systematic review. Dan Med J 2012; 59:A4357.
29. Becker KI, Silva OI, Snider RH The pathophysiology of pulmonary procalcitonin. The endocrine lung in health and disease. Becker KI, Gazdar AF, eds. Philadelphia, WB Saunders 1984: 277-99.
30. Kishaba T, Shimaoka Y, Fukuyama H., et al. A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema. BMJ Open 2012; 2:e000988.
31. Wang IM, Stepaniants S, Boie Y., et al. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am J Respir Crit Care Med 2008; 177: 402-11. (Pubitemid 351317583)
32. Cederqvist K, Sirén V, Petäjä J, et al. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome. Pediatrics 2006; 117: 1226-34. (Pubitemid 46071516)
33. Sisson TH, Hanson KE, Subbotina N, et al Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2002; 283: L1023-32. (Pubitemid 35204894)
34. Barnes PJ. Corticosteroid effects on signaling. Eur Respir J 2006; 27: 413-26.